3M Drug Delivery Systems has designed a proof-of-concept device using a solid microstructured transdermal system (sMTS) for the systemic delivery of high potency pharmaceuticals. The technology was showcased this week at the annual meeting of the Controlled Release Society in New York, where John K. Simons, Ph.D., microstructured transdermal project manager at the company, explained the in vivo data, including depth of penetration, timed release, and demonstration of systemic delivery. The re...